UTERINE CORPUS MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Clinical trials for UTERINE CORPUS MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR explained in plain language.

Never miss a new study

Get alerted when new UTERINE CORPUS MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

Sign up with your email to follow new studies for UTERINE CORPUS MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Breakthrough trial aims to outsmart aggressive uterine cancer

Disease control Recruiting now

This study is testing if adding newer, faster-to-administer targeted drugs to standard chemotherapy works better for people with a specific type of advanced uterine cancer (HER2-positive). It will involve 360 participants who have not had prior chemotherapy. The main goal is to s…

Matched conditions: UTERINE CORPUS MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Phase: PHASE3 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Mar 13, 2026 15:05 UTC

UTERINE CORPUS MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR

Get alerted when new UTERINE CORPUS MALIGNANT MIXED MESODERMAL (MULLERIAN) TUMOR trials appear

Breakthrough trial aims to outsmart aggressive uterine cancer